BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 22956143)

  • 1. Antagomirbase- a putative antagomir database.
    Ganguli S; Mitra S; Datta A
    Bioinformation; 2011; 7(1):41-3. PubMed ID: 21904438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipose tissue macrophages secrete small extracellular vesicles that mediate rosiglitazone-induced insulin sensitization.
    Rohm TV; Castellani Gomes Dos Reis F; Isaac R; Murphy C; Cunha E Rocha K; Bandyopadhyay G; Gao H; Libster AM; Zapata RC; Lee YS; Ying W; Miciano C; Wang A; Olefsky JM
    Nat Metab; 2024 May; 6(5):880-898. PubMed ID: 38605183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances and Obstacles in Using CRISPR/Cas9 Technology for Non-Coding RNA Gene Knockout in Human Mesenchymal Stromal Cells.
    Basalova N; Illarionova M; Skryabina M; Vigovskiy M; Tolstoluzhinskaya A; Primak A; Chechekhina E; Chechekhin V; Karagyaur M; Efimenko A
    Noncoding RNA; 2023 Aug; 9(5):. PubMed ID: 37736895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symbiosis preservation: Putative regulation of fatty acyl-CoA reductase by miR-31a within the symbiont harboring bacteriome through tsetse evolution.
    Lee MH; Hu G; Rio RVM
    Front Microbiol; 2023; 14():1151319. PubMed ID: 37113220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid and Peptide-Oligonucleotide Conjugates for Therapeutic Purposes: From Simple Hybrids to Complex Multifunctional Assemblies.
    Fàbrega C; Aviñó A; Navarro N; Jorge AF; Grijalvo S; Eritja R
    Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyclotides, tetrahydrofuran-modified peptide nucleic acids that efficiently penetrate cells and inhibit microRNA-21.
    Clausse V; Zheng H; Amarasekara H; Kruhlak M; Appella DH
    Nucleic Acids Res; 2022 Oct; 50(19):10839-10856. PubMed ID: 36215040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of microRNA in the pathogenesis of glial brain tumors.
    Beylerli O; Gareev I; Sufianov A; Ilyasova T; Zhang F
    Noncoding RNA Res; 2022 Jun; 7(2):71-76. PubMed ID: 35330864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal regulation of microRNA expression dynamics in the gut of the yellow fever mosquito
    Zhang X; Raikhel AS
    RNA Biol; 2021 Nov; 18(11):1682-1691. PubMed ID: 33317406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next generation miRNA inhibition using short anti-seed PNAs encapsulated in PLGA nanoparticles.
    Malik S; Lim J; Slack FJ; Braddock DT; Bahal R
    J Control Release; 2020 Nov; 327():406-419. PubMed ID: 32835710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial focus: understanding off-target effects as the key to successful RNAi therapy.
    Bartoszewski R; Sikorski AF
    Cell Mol Biol Lett; 2019; 24():69. PubMed ID: 31867046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-administration of Anti microRNA-124 and -137 Oligonucleotides Prevents Hippocampal Neural Stem Cell Loss Upon Non-convulsive Seizures.
    Bielefeld P; Schouten M; Meijer GM; Breuk MJ; Geijtenbeek K; Karayel S; Tiaglik A; Vuuregge AH; Willems RAL; Witkamp D; Lucassen PJ; Encinas JM; Fitzsimons CP
    Front Mol Neurosci; 2019; 12():31. PubMed ID: 30837840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs and cancer: Key paradigms in molecular therapy.
    Tan W; Liu B; Qu S; Liang G; Luo W; Gong C
    Oncol Lett; 2018 Mar; 15(3):2735-2742. PubMed ID: 29434998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of miRNAs in Angiogenesis, Invasion and Metabolism and Their Therapeutic Implications in Gliomas.
    Beyer S; Fleming J; Meng W; Singh R; Haque SJ; Chakravarti A
    Cancers (Basel); 2017 Jul; 9(7):. PubMed ID: 28698530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring integrity and localization of modified single-stranded RNA oligonucleotides using ultrasensitive fluorescence methods.
    Heissig P; Schrimpf W; Hadwiger P; Wagner E; Lamb DC
    PLoS One; 2017; 12(3):e0173401. PubMed ID: 28278199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulated expression of microRNAs and mRNAs in myocardial infarction.
    Wang Y; Pan X; Fan Y; Hu X; Liu X; Xiang M; Wang J
    Am J Transl Res; 2015; 7(11):2291-304. PubMed ID: 26807177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic antagonists of microRNAs deplete leukemia-initiating cell activity.
    Velu CS; Chaubey A; Phelan JD; Horman SR; Wunderlich M; Guzman ML; Jegga AG; Zeleznik-Le NJ; Chen J; Mulloy JC; Cancelas JA; Jordan CT; Aronow BJ; Marcucci G; Bhat B; Gebelein B; Grimes HL
    J Clin Invest; 2014 Jan; 124(1):222-36. PubMed ID: 24334453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From microRNA functions to microRNA therapeutics: novel targets and novel drugs in breast cancer research and treatment (Review).
    Piva R; Spandidos DA; Gambari R
    Int J Oncol; 2013 Oct; 43(4):985-94. PubMed ID: 23939688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilizing antagomiR (antisense microRNA) to knock down microRNA in murine bone marrow cells.
    Velu CS; Grimes HL
    Methods Mol Biol; 2012; 928():185-95. PubMed ID: 22956143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systems biology-based investigation of cooperating microRNAs as monotherapy or adjuvant therapy in cancer.
    Lai X; Eberhardt M; Schmitz U; Vera J
    Nucleic Acids Res; 2019 Sep; 47(15):7753-7766. PubMed ID: 31340025
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.